Real-world Treatment Duration in Patients with Non-small Cell Lung Cancer (NSCLC) With EGFR Exon20 Insertion (EGFRex20ins) Mutations Receiving Mobocertinib Through the Global Expanded Access Program (EAP)
Mobocertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Real-world Treatment Duration in Patients with Non-small Cell Lung Cancer (NSCLC) With EGFR Exon20 Insertion (EGFRex20ins) Mutations Receiving Mobocertinib Through the Global Expanded Access Program (EAP) ### Output: Mobocertinib